A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC
Recruiting · NCT06699121 · Registry updated 2025-10-24Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Assess the Safety and Efficacy of LB-P8 in Patients With PSC | Cholangitis, Sclerosing, Digestive System Diseases, Pathological Conditions, Signs and Symptoms, Pruritus, Signs and Symptoms, Skin Manifestations, Skin and Connective Tissue Diseases, bile duct disorder, biliary tract disorder, cholangitis, cholestasis, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, skin disorder | Recruiting | Phase 2 | 2025-10-24 | NCT06699121 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| LISCure Biosciences | 1 |
7 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Liver Institute Northwest | Seattle | United States | 11 |
| Mayo Clinic | Rochester | United States | 664 |
| Mercy Medical Center | Baltimore | United States | 40 |
| The Vanderbilt Clinic | Nashville | United States | 2 |
| UCHealth University of Colorado Hospital | Aurora | United States | 172 |
| University of California Davis | Sacramento | United States | 34 |
| University of Iowa Hospitals and Clinics | Iowa City | United States | 99 |